This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Intelligent Automation, LLC, a small business contractor. The contract is titled "AMADEUS: ACUTE MARIJUANA INTOXICATION DETECTION USING DIGITAL MARKERS" and has a period of performance from September 30, 2018 to September 29, 2019 with a potential value of $225,000. The contract is a Definitive Contract with a Firm Fixed Price...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract, valued at $225,000.00, is for the development of a system to specify acute tetrahydrocannabinol (THC) impairment using validated algorithms. The period of performance is from September 30, 2018 to March 30,...
This SBIR Phase I contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Advanced Brain Monitoring, Inc., a for-profit small business and veteran-owned manufacturer of medical equipment. The contract, valued at $225,000.00, is for the development of a Cannabis Impairment Detection Application (CIDA) to support research into detecting cannabis impairment. This award was set aside for small businesses. Advanced Brain Monitoring has a history of...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase II contract to Advanced Brain Monitoring, Inc., a for-profit veteran-owned manufacturer of medical devices and equipment. The contract, valued at $1,499,722.00, is for the development of a Cannabis Impairment Detection Application (CIDA) and has a period of performance from September 20, 2019, to September 19, 2021. Advanced Brain...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Vala Sciences Inc. to conduct Small Business Innovation Research (SBIR) Phase I research and development on the "Development of Novel In-Vitro and In-Vivo Models to Support NeuroHIV Research." The contract was set aside for small businesses and has an ultimate completion date of September 26, 2025. Vala Sciences...
This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...
This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $279,993.00, was awarded to We The Village, Inc., a for-profit organization, to develop a scalable digital platform for delivering evidence-based training to families to increase treatment admission rates for loved ones with opioid use...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $223,874 Small Business Innovation Research (SBIR) Phase I research contract to Medical Decision Logic Inc., a minority-owned, self-certified small disadvantaged business. The contract, which has a firm fixed price, is focused on an unspecified research topic under the SBIR program and has a completion date of March 31, 2020. Medical Decision Logic Inc. has previously provided...
This federal contract award, valued at $15,000.00, was issued by the National Institute on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to International Behavioral Methods and Development (IBMD), a for-profit organization, to provide training and supervision of research assistants who will administer clinical and ecological momentary assessment (ESM) measures, as well as develop new...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Valenti, Denise A, doing business as Immad, a self-certified small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for $225,000.00 to develop digital markers for measuring marijuana intoxication through the dysfunctional response of retinal ganglion cells. The original solicitation was part of the HHS/NIH/Centers for Disease Control and Prevention (CDC) SBIR Contract Solicitation PHS 2018-1, which included research topics across multiple NIH Institutes and CDC Centers. This contract is set aside for small business.